Navigation Links
RHEI Pharmaceuticals Licenses Attental From MethaPharma (Vemedia Group) for Distribution Throughout Asia
Date:2/19/2008

- Natural Supplement for Attention-Deficit Hyperactivity Disorder in

Children Fulfills Growing Need Throughout Asia -

NEW HAVEN, Conn. and KORTRIJK, Belgium, Feb. 19 /PRNewswire/ -- RHEI Pharmaceuticals, Inc., a fully integrated specialty pharmaceuticals company focused on bringing proprietary medicines to the China market, and MethaPharma, part of then Vemedia Group, today announced that RHEI has licensed from MethaPharma the exclusive right to market and distribute Attental(R) throughout Asia. Attental is a nutraceutical currently commercially available in Europe for attention-deficit hyperactivity disorder (ADHD) in children.

"There is a great opportunity for Attental throughout Asia where parents prefer giving their children natural products versus prescription drugs," said Joos Horsten, Executive Chairman and Chief Executive Officer of RHEI. "There has been a growing awareness of ADHD in Asia as a more western diet and lifestyle is adopted. In addition, there are now several government programs in place to train doctors and teachers to better identify and treat children suffering from ADHD. RHEI will utilize its experience in pharmaceutical marketing and its network of contacts, particularly within the pediatric community, to bring this important natural remedy to the Asian market."

Attental has been proven in a randomized, double-blind, placebo controlled clinical trial to better overall motor performance and improve reading and spelling in children. The clinical trial demonstrated a significant improvement in the Conners' Teaching Rating Scale-L (CTRS-L) of 59 items describing different aspects of child behavior, as well as in the Child Behavior Checklist (CBCL) -- standard evaluation methods for ADHD.

"RHEI's approach which includes a hospital-based sales force in China that understands the scientific aspects of ADHD and can communicate the benefits of Attental, combined with their experience in direct to co
'/>"/>

SOURCE RHEI Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled
2. NUCRYST Pharmaceuticals announces year-end results
3. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
4. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
5. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
6. American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals
7. MedThink Communications Selected by Salix Pharmaceuticals to Launch New Product
8. Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program
9. Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer
10. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
11. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...-Everest Team has announced at the Cheltenham Scie...edition team to mount Everest to conduct //a resea... Doctors and scientists from the Centre for Aviat...dicine at the Institute of Human Health and Perfor...
...through move against HIV drug resistance, scientis...aturation Inhibitors that is the first in a new cl...nt the formation of Caspsid, a key viral protein f...rug in question, PA- 457, is a derivative of betul...
... Thwala, the Ministry of Agriculture Director of V...President of the African Regional Commission //for...tion for Animal Health (OIE). Dr. Barry O’Neil wa.... This post is held for three years. The elections...
... is enthralling people with his magic tricks or de...fessor Gursharan Singh Chhatwal does both with eas... a gifted magician. But the scientist from India h...is work against the killer streptococci bacteria. ...
Other Medicine News:Health News:Mount Everest to be Site of Research into Hypoxia 2Health News:Indian Scientist who Enthralls Public With Magic Tricks 2
(Date:10/10/2008)... -- Diplomat Specialty,Pharmacy announced today th...ty Pharmacy to be one of only three sites to parti...tion Study for Multiple Sclerosis (TOP MS)., The ...the benefits of a,specialty pharmacy therapy manag... outcomes. Targeted patient outcomes will include:...
(Date:10/10/2008)...-- TriReme Medical Inc. (TMI),announced today that...e,Europeenne) marking and commercialize in Europe ...in vessel stent system specially designed for use,...he next generation in bifurcation stenting, the,An... the 2.2 million,angioplasty procedures performed ...
(Date:10/9/2008)...ember 2008, BOTHELL, Wash., Oct. 9 /PRNewswire-Fi...nced today the completion of patient enrollment an... to evaluate the safety and,efficacy of its formul...or,the over-the-counter (OTC) market. The Company ...al trial in November 2008. Ibuprofen is an analges...
(Date:10/8/2008)...etics and Chemicals Testing, ASHLAND, Mass., Oct....at results of a recently completed US and European...atTek,s EpiDerm in vitro human skin tissue,equival...nsitivity and,specificity for EpiDerm to be accept...r determining human skin irritation by the Europea...
Breaking Medicine Technology:Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2University of Maryland Baltimore BioPark Signs Gliknik Inc as First Tenant in Its BioInnovation Center in Building Two 2532 1University of Maryland Baltimore BioPark Signs Gliknik Inc as First Tenant in Its BioInnovation Center in Building Two 2532 2Dey L P Settles State of Alabama Pricing Litigation 9349 1Dey L P Settles State of Alabama Pricing Litigation 9349 2Hiemstra Approved to Manufacture Medical Devices in New CER 9345 1Hiemstra Approved to Manufacture Medical Devices in New CER 9345 2Keep a Watchful Eye on Sugary Beverage Consumption 9341 1Keep a Watchful Eye on Sugary Beverage Consumption 9341 2
...SINESS WIRE)--Jun 11, 2007 - Geron,Corporation (Na...earch studies indicating that GRNOPC1, the company...tic for the treatment of,spinal cord injury, evade...sented by Geron scientist Ross Okamura at the Fede... San Diego, the findings,could mean that patients ...
...007-ReGen is pleased to announce that,a review of ..., its,nutraceutical product which the Company beli...e function, was presented today at the,2007 Intern...radise, Queensland, Australia by Dr Marian Kruzel,...e, which is being attended by key opinion leaders,...
Other Medicine Technology:Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3Data Showing that ReGen's Colostrinin Supports Healthy Cognitive,Function Presented at the 2007 International Congress on Natural,Medicine in Australia 2
Humerus Fracture Brace indications: , Nonoperative treatment of closed humeral shaft fractures , Postoperative treatment of open humeral shaft fractures , Protection of humeral defects , After rem
The FUNCTIONAL ARM BRACE (FAB) was designed to allow immobilization in multiple positions to make it useful as a functional brace in early rehabilitation., ,Far more than an "Elbow ROM Brace" - the
Controls humeral segments through soft tissue compression while allowing for full range of elbow motion
...This simple concept is the cornerstone of our Town...k the heel with our patent-pending Stablelock Syst...t your patient will experience walking in their TS... and supports the posterior aspect of the leg. Thi...
Medicine Products: